Literature DB >> 9475663

Histamine and the response to IFN-alpha in chronic hepatitis C.

K Hellstrand1, M Brune, U H Mellqvist, G Norkrans, P A Lundberg, S Hermodsson, R Wejstål.   

Abstract

Whole blood concentrations of histamine were examined in 20 patients with chronic hepatitis C after longterm treatment with interferon-alpha (IFN-alpha). In 13 of these patients, a transient (n = 5) or sustained (n = 8) normalization of liver enzymes and elimination of viral RNA were noted at the end of therapy. Seven patients did not respond to IFN-alpha. Nonresponding patients had significantly lower histamine levels in blood than transient (p = 0.0005) or sustained (p = 0.04) responders. Histamine levels were not different in patients with a sustained vs. a transient IFN response. Confounding factors, such as ongoing viral replication or liver cirrhosis, did not account for the differences in histamine levels. Our data suggest that hypohistaminism in peripheral blood may determine a poor response to IFN-alpha in chronic hepatitis C.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9475663     DOI: 10.1089/jir.1998.18.21

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  1 in total

1.  Histamine dihydrochloride protects against early alcohol-induced liver injury in a rat model.

Authors:  Stephen C Hornyak; Kurt R Gehlsen; Tapio Haaparanta
Journal:  Inflammation       Date:  2003-10       Impact factor: 4.092

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.